CD33 and cervical cancer: As shown in Fig. 5a, significantly higher numbers of tumor-infiltrating MDSC (CD33+ cells) were observed in the lymph nodes from TRL-positive cervical cancer patients than in those from TRL-negative cervical cancer patients.